Suppr超能文献

晚期慢性淋巴细胞白血病的脾切除术

Splenectomy in advanced chronic lymphocytic leukemia.

作者信息

Ferrant A, Michaux J L, Sokal G

出版信息

Cancer. 1986 Nov 1;58(9):2130-5. doi: 10.1002/1097-0142(19861101)58:9<2130::aid-cncr2820580928>3.0.co;2-3.

Abstract

Forty chronic lymphocytic leukemia patients with splenomegaly were evaluated for splenectomy. Twenty were splenectomized. All but two normalized their hematocrit and all but one their platelet count. Satisfactory residual erythropoiesis as evaluated using ferrokinetics enabled prediction of a good response to splenectomy in 18 of 20 patients. The two patients who did not respond despite satisfactory residual erythropoiesis had a deteriorating blood count after splenectomy with progressive disease. The measurement of the splenic red cell volume predicted the minimal increase in hematocrit that could be expected after splenectomy. The transfusion need was abolished in 13 of 14 patients who needed red cell transfusions before splenectomy. Despite clinical improvement after the operation in all but two patients, splenectomized patients did not survive longer than nonsplenectomized patients, whether survival probability was calculated from the time of diagnosis or from the time of evaluation.

摘要

对40例伴有脾肿大的慢性淋巴细胞白血病患者进行了脾切除术评估。其中20例行脾切除术。除2例患者外,其余患者的血细胞比容均恢复正常,除1例患者外,其余患者的血小板计数也恢复正常。通过铁动力学评估的满意的残余红细胞生成能够预测20例患者中有18例对脾切除术有良好反应。尽管残余红细胞生成满意,但仍无反应的2例患者在脾切除术后血细胞计数恶化且病情进展。脾红细胞体积的测量可预测脾切除术后预期的血细胞比容最小增加量。14例脾切除术前需要红细胞输血的患者中有13例术后不再需要输血。除2例患者外,其余患者术后临床症状均有改善,但无论从诊断时间还是评估时间计算生存概率,脾切除患者的生存期均不长于未行脾切除的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验